101 results
Page 3 of 6
8-K
onub4lkm1fg72srjgp
25 May 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
EX-99.1
ppkajewpp8vv
16 Feb 22
Avenue Therapeutics Announces Outcome of FDA Advisory Committee Meeting on IV Tramadol
7:39am
424B5
80hi n74n2g9s5
13 Dec 21
Prospectus supplement for primary offering
9:19am
424B5
esax 2gkb6
10 Dec 21
Prospectus supplement for primary offering
5:25pm
424B5
oe0d3oo7oj1zr
10 Nov 21
Prospectus supplement for primary offering
5:25pm
424B5
l407hj4fdyfiqi
9 Nov 21
Prospectus supplement for primary offering
5:14pm
8-K
EX-99.1
rpl4d5
14 Jun 21
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
9:00am
8-K
EX-99.1
5fg st314e
17 Dec 20
Avenue Therapeutics Provides Regulatory Update for IV Tramadol
9:02am
8-K
EX-99.1
q4xxv 52nthgpfmv
13 Oct 20
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
6:10am
8-K
EX-99.1
qh0lux ql
14 Aug 20
Avenue Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights
8:30am